col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


67 Results       Page 1

 [1] 
Elsevier: Cytokine
  original article Date Title Authors   All Authors
1 [GO] 2022―Aug―29 A Meta-summary and Bioinformatic Analysis Identified Interleukin 6 as a Master Regulator of COVID-19 Severity Biomarkers Mohannad Ghanem, Sharon J Brown, Aysha EAT Mohamed, Heidi R Fuller
2 [GO] 2022―Aug―29 IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in Sweden Louise Ziegler, Annika Lundström, Sebastian Havervall, Charlotte Thålin, Bruna Gigante
3 [GO] 2022―Aug―11 The non-functional ACE2 isoform, but not the SARS-CoV-2 receptor, is induced as an interferon-stimulated gene, in SARS-CoV-2 infected adults Giuseppe Oliveto, Carolina Scagnolari, Federica Frasca, Leonardo Sorrentino, Luigi Matera, Raffaella Nenna, et al. (+10)
4 [GO] 2022―Jul―31 COVID-19 imparted immune manifestation can be combated by NLGP: Lessons from cancer research Anamika Bose, Rathindranath Baral
5 [GO] 2022―Jul―28 Prognostic significance of serum galectin-3 in hospitalized patients with COVID-19 Sevgi Özcan, Esra Dönmez, Sevil Tuğrul Yavuz, Murat Ziyrek, Orhan İnce, H.Suat Küçük, et al. (+5)
6 [GO] 2022―Jul―25 Acute kidney injury associated to COVID-19 leads to a strong unbalance of circulant immune mediators Thalia Medeiros, Gabriel Macedo Costa Guimarães, Fabiana Rabe Carvalho, Lilian Santos Alves, Renan Faustino, Ana Carolina Campi-Azevedo, et al. (+8)
7 [GO] 2022―Jul―22 Is IFN expression by NK cells a hallmark of severe COVID-19? Bárbara Guimarães Csordas, Pedro Henrique de Sousa Palmeira, Rephany Fonseca Peixoto, Fernando Cézar Comberlang Queiroz Davis dos Santos, Isac Almeida de Medeiros, Fátima de Lourdes Assunção Araújo de Azevedo, et al. (+5)
8 [GO] 2022―Jul―18 Distinct type I interferon responses between younger women and older men contribute to the variability of COVID-19 outcomes: Hypothesis generating insights from COVID-19 convalescent individuals Clio P. Mavragani, Charalampos Skarlis, Ioannis V. Kostopoulos, Eirini Maratou, Paraskevi Moutsatsou, Evangelos Terpos, et al. (+3)
9 [GO] 2022―Jul―02 Impact of interferon-induced transmembrane protein 3 gene rs12252 polymorphism on COVID-19 mortality Iraj Ahmadi, Alireza Afifipour, Fatemeh Sakhaee, Mohammad Saber Zamani, Fahimeh Mirzaei Gheinari, Enayat Anvari, Abolfazl Fateh
10 [GO] 2022―Jun―07 Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: From prognostic marker to therapeutic agent Jozefien Declercq, Elisabeth De Leeuw, Bart N. Lambrecht
11 [GO] 2022―Apr―25 Cytokine response over the course of COVID-19 infection in pregnant women Daniel B. Rosen, Elisabeth A. Murphy, Ron S. Gejman, Allyson Capili, Rachel L. Friedlander, Sophie Rand, et al. (+8)
12 [GO] 2022―Apr―19 Evaluation of the relationship between IL-6 gene single nucleotide polymorphisms and the severity of COVID-19 in an Iranian population Sara Falahi, Mohammad Hossein Zamanian, Parisa Feizollahi, Alireza Rezaiemanesh, Farhad Salari, Zahra Mahmoudi, Ali Gorgin Karaji
13 [GO] 2022―Apr―05 SARS-CoV-2 triggering autoimmune diseases Leila Mobasheri, Mohammad Hossein Nasirpour, Elham Masoumi, Afsaneh Foolady Azarnaminy, Mozhdeh Jafari, Seyed-Alireza Esmaeili
14 [GO] 2022―Apr―04 Up-regulated Serum Levels of Interleukin (IL)-17A and IL-22 in Egyptian Pediatric Patients with COVID-19 and MIS-C: Relation to the Disease Outcome Gehan Ahmed Mostafa, Hanan Mohamed Ibrahim, Abeer Al Sayed Shehab, Sondos Mohamed Magdy, Nada AboAbdoun Soliman, Dalia Fathy El-Sherif
15 [GO] 2022―Mar―28 Clinical monitored in subjects metabolically healthy and unhealthy before and during a SARS-CoV-2 infection- A cross-sectional study in Mexican population Samuel Treviño, Steffany Cortezano-Esteban, Hugo Hernández-Fragoso, Alfonso Díaz, Rubén Vázquez-Roque, Victor Enrique Sarmiento-Ortega, et al. (+3)
16 [GO] 2022―Mar―04 Expression analysis of IFNAR1 and TYK2 transcripts in COVID-19 patients Mohammadarian Akbari, Mehdi Akhavan-Bahabadi, Navid Shafigh, Afshin Taheriazam, Bashdar Mahmud Hussen, Arezou Sayad, et al. (+4)
17 [GO] 2022―Feb―10 SARS-CoV-2 infection causes intestinal cell damage: Role of interferon’s imbalance Stefany Guimarães Sousa, Antônio Kleiton de Sousa, Cynthia Maria Carvalho Pereira, Anna Sofia Miranda Loiola Araújo, Diva de Aguiar Magalhães, Tarcisio Vieira de Brito, André Luiz dos Reis Barbosa
18 [GO] 2022―Feb―01 Hemoperfusion during veno-venous ECMO in severe COVID-19 with IL-6 elevation Giovanni Giordano, Francesco Alessandri, Francesco Pugliese
19 [GO] 2022―Jan―31 Elevated plasma levels of CXCL16 in severe COVID-19 patients Sandra P. Smieszek, Vasilios M. Polymeropoulos, Christos M. Polymeropoulos, Bartlomiej P. Przychodzen, Gunther Birznieks, Mihael H. Polymeropoulos
20 [GO] 2022―Jan―18 Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis Laura Bergantini, Miriana d'Alessandro, Paolo Cameli, Ambra Otranto, Simona Luzzi, Francesco Bianchi, Elena Bargagli
21 [GO] 2021―Dec―25 Role of immune mediators in predicting hospitalization of SARS-CoV-2 positive patients S. Ashrafzadeh-Kian, M.R. Campbell, J.C. Jara Aguirre, J. Walsh, A. Kumanovics, G. Jenkinson, et al. (+3)
22 [GO] 2021―Dec―14 Effect of SARS-CoV-2 seropositivity on antigen - specific cytokine and chemokine responses in latent tuberculosis Anuradha Rajamanickam, Nathella Pavan Kumar, Padmapriyadarsini Chandrasekaran, Arul Nancy, P.K. Bhavani, Nandhini Selvaraj, et al. (+7)
23 [GO] 2021―Nov―06 In-vitro cytokine production and nasopharyngeal microbiota composition in the early stage of COVID-19 infection Mehmet Hursitoglu, Nilgun Isıksacan, Betul Erismis, Faruk Karandere, Alev Kural, A.Baki Kumbasar, Kadriye Kart Yasar
24 [GO] 2021―Nov―06 Association and predictive value of biomarkers with severe outcomes in hospitalized patients with sars-cov-2 infection Rafael Fernandez-Botran, Stephen Furmanek, Raghava Sekhar Ambadapoodi, Evelyn Expósito González, Meredith Cahill, Ruth Carrico, et al. (+2)
25 [GO] 2021―Oct―29 Corrigendum to “Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients” [Cytokine 148 (2021) 155662] Sandra P. Smieszek, Bartlomiej P. Przychodzen, Vasilios M. Polymeropoulos, Bushra A. Mina, Christos M. Polymeropoulos, Mihael H. Polymeropoulos
26 [GO] 2021―Oct―06 Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: a prospective observational study Elena Sancho Ferrando, Katja Hanslin, Michael Hultström, Anders Larsson, Robert Frithiof, Miklos Lipcsey
27 [GO] 2021―Oct―06 IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19? Chia Siang Kow, Abdullah Faiz Zaihan, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
28 [GO] 2021―Sep―27 Randomized trial drug controlled compendious transcriptome analysis supporting broad and phase specific therapeutic potential of multiple candidates in COVID-19 Abhay Sharma
29 [GO] 2021―Sep―09 Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19) Aeshah A. Ahmed, Ali H. Ad'hiah
30 [GO] 2021―Sep―03 SARS-CoV-2 3C-like protease antagonizes interferon-beta production by facilitating the degradation of IRF3 Wenwen Zhang, Zhenling Ma, Yaru Wu, Xixi Shi, Yanyan Zhang, Min Zhang, et al. (+3)
31 [GO] 2021―Aug―06 COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us? Claudio G. Gallo, Sirio Fiorino, Giovanni Posabella, Donato Antonacci, Antonio Tropeano, Emanuele Pausini, et al. (+9)
32 [GO] 2021―Jul―29 Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients’ Sandra P. Smieszek, Bartlomiej P. Przychodzen, Vasilios Polymeropoulos, Christos Polymeropoulos, Mihael H. Polymeropoulos
33 [GO] 2021―Jul―03 Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: A pilot study Sergey N. Avdeev, Natalia V. Trushenko, Natalia A. Tsareva, Andrey I. Yaroshetskiy, Zamira M. Merzhoeva, Galia S. Nuralieva, et al. (+5)
34 [GO] 2021―Jul―03 Clinical Applications of Thrombopoietin Silencing: A Possible Therapeutic Role in COVID-19? Vincent J. Alentado, Alison R. Moliterno, Edward F. Srour, Melissa A. Kacena
35 [GO] 2021―Jul―03 Between immunomodulation and immunotolerance: The role of IFNγ in SARS-CoV-2 disease Nataša Todorović-Raković, Jonathan R. Whitfield
36 [GO] 2021―Jun―07 Type 1 inflammatory endotype relates to low compliance, lung fibrosis, and severe complications in COVID-19 Takehiro Hasegawa, Atsushi Nakagawa, Kohjin Suzuki, Kazuto Yamashita, Saya Yamashita, Niina Iwanaga, et al. (+3)
37 [GO] 2021―May―26 The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all? Gerwyn Morris, Chiara C Bortolasci, Basant K Puri, Wolfgang Marx, Adrienne O'Neil, Eugene Athan, et al. (+5)
38 [GO] 2021―May―24 Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients A. Gradin, H. Andersson, T. Luther, S. Bülow Anderberg, S. Rubertsson, M. Lipcsey, et al. (+4)
39 [GO] 2021―Apr―19 Perspectives on anti-IL-1 inhibitors as potential therapeutic interventions for severe COVID-19 Jie Geng, Feng Wang, Zhiwei Huang, Xiaobo Chen, Yuliang Wang
40 [GO] 2021―Apr―19 Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico Azalia Avila-Nava, Arturo Cortes-Telles, Darwin Torres- Erazo, Stephanie López-Romero, Rodolfo Chim Aké, Ana Ligia Gutiérrez Solis
41 [GO] 2021―Apr―01 Aberrant Cytokine Expression in COVID-19 Patients: Associations between Cytokines and Disease Severity Yueting Tang, Jiayu Sun, Huaqin Pan, Fen Yao, Yumeng Yuan, Mi Zeng, et al. (+12)
42 [GO] 2021―Mar―27 IL-6 and IL-10 are associated with disease severity and a higher comorbidity in adults with COVID-19 Rafael Luís Luporini, Joice M. de A. Rodolpho, Lauro Tatsuo Kubota, Ana Carolina Baptista Moreno Martin, Marcia R. Cominetti, Fernanda de Freitas Anibal, Henrique Pott-Junior
43 [GO] 2021―Mar―26 Clinical relevance of serum Krebs von den Lungen-6 levels in patients with coronavirus disease 2019 Hao Chen, Rundong Qin, Zhifeng Huang, Wenting Luo, Peiyan Zheng, Huimin Huang, et al. (+3)
44 [GO] 2021―Mar―20 Serum IP-10 and IL-7 levels are associated with disease severity of coronavirus disease 2019 Guo-Lin Wang, Hui-Xia Gao, Yu-Ling Wang, Xiao Wei, Yu-Zhen Liu, Jian-Hua Lu, et al. (+10)
45 [GO] 2021―Mar―14 Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication Pruthvi Gowda, Shruti Patrick, Shanker Datt Joshi, Rajesh Kumar Kumawat, Ellora Sen
46 [GO] 2021―Mar―07 The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19 Kristina Schönfelder, Katharina Breuckmann, Carina Elsner, Ulf Dittmer, David Fistera, Frank Herbstreit, et al. (+8)
47 [GO] 2021―Feb―23 Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: a review Benjamin M. Liu, Thomas B Martins, Lisa K. Peterson, Harry R. Hill
48 [GO] 2021―Feb―03 “The prognostic role of IL-10 in non-severe COVID-19 with chemosensory dysfunction” Luca Giovanni Locatello, Chiara Bruno, Giandomenico Maggiore, Maria Cilona, Pietro Orlando, Giuseppe Fancello, et al. (+5)
49 [GO] 2021―Jan―28 Prognostic bioindicators in severe COVID-19 patients L. Bergantini, E. Bargagli, M. d'Alessandro, R.M. Refini, P. Cameli, L. Galasso, et al. (+9)
50 [GO] 2021―Jan―18 Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome? Ramin Sami, Farshid Fathi, Nahid Eskandari, Meysam Ahmadi, Reza ArefNezhad, Hossein Motedayyen
51 [GO] 2021―Jan―18 Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19 Wafa Sayah, Ismahane Berkane, Imène Guermache, Mohamed Sabri, Fatma Zahra Lakhal, Sarah Yasmine Rahali, et al. (+19)
52 [GO] 2021―Jan―18 The Impact of COVID-19 Infection On The Cytokine Profile of Pregnant Women: A Prospective Case-Control Study Atakan Tanacan, Nuray Yazihan, Seyit Ahmet Erol, Ali Taner Anuk, Fatma Didem Yucel Yetiskin, Derya Biriken, et al. (+4)
53 [GO] 2021―Jan―18 Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia Luca Quartuccio, Martina Fabris, Arianna Sonaglia, Maddalena Peghin, Rossana Domenis, Adriana Cifé, et al. (+2)
54 [GO] 2021―Jan―18 ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry? Carolina Scagnolari, Camilla Bitossi, Agnese Viscido, Federica Frasca, Giuseppe Oliveto, Mirko Scordio, et al. (+8)
55 [GO] 2020―Dec―16 Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients Sara Bülow Anderberg, Tomas Luther, Malin Berglund, Rolf Larsson, Sten Rubertsson, Miklos Lipcsey, et al. (+3)
56 [GO] 2020―Dec―15 Experience of using tocilizumab for treatment in Indonesian patients with severe COVID-19 Allen Widysanto, Andree Kurniawan, Nata Pratama Hardjo Lugito, Mira Yuniarti, Catherine Gunawan, Jessica Wiryanto, Tasya Meidy Pradhana
57 [GO] 2020―Dec―11 Cytokine Storm Induced by SARS-CoV-2 Infection: The Spectrum of its Neurological Manifestations Parisorn Thepmankorn, John Bach, Ahmed Lasfar, Xilin Zhao, Sami Souayah, Zhao Zhong Chong, Nizar Souayah
58 [GO] 2020―Dec―09 A nuclear factor kappa B reporter cell line used to evaluate ex vivo the net inflammatory effect of plasma samples from patients with rheumatoid arthritis, psoriasis, or COVID-19 Lelia Wagner, Walter E. Haefeli, Uta Merle, Hanns-Martin Lorenz, Nicolas Hohmann, Johanna Weiss, Dirk Theile
59 [GO] 2020―Nov―09 An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis Yili Liu, Daihong Chen, Junjie Hou, Haicong Li, Dan Cao, Mingquan Guo, et al. (+5)
60 [GO] 2020―Oct―23 The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19 Juan Gómez, Guillermo M. Albaiceta, Elías Cuesta-Llavona, Marta García-Clemente, Carlos López-Larrea, Laura Amado-Rodríguez, et al. (+9)
61 [GO] 2020―Oct―12 Probable Positive Effects of the Photobiomodulation as an Adjunctive Treatment in COVID-19: A Systematic Review Marzieh Nejatifard, Sohrab Asefi, Raika Jamali, Michael R. Hamblin, Reza Fekrazad
62 [GO] 2020―Sep―30 Cytokine Profile and Disease Severity in Patients with COVID-19 Ali Ghazavi, Ali Ganji, Nafiseh Keshavarzian, Somayeh Rabiemajd, Ghasem Mosayebi
63 [GO] 2020―Sep―29 Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19 Hasan Satış, Hasan Selçuk Özger, Pınar Aysert Yıldız, Kenan Hızel, Özlem Gulbahar, Gonca Erbaş, et al. (+5)
64 [GO] 2020―Aug―20 ADE and hyperinflammation in SARS-CoV2 infection- Comparison with dengue hemorrhagic fever and feline infectious peritonitis Maryse Cloutier, Madhuparna Nandi, Awais Ullah Ihsan, Hugues Allard Chamard, Subburaj Ilangumaran, Sheela Ramanathan
65 [GO] 2020―Aug―15 A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases Abdullah Mahmud-Al-Rafat, Md. Muzammal Haque Asim, Andrew W. Taylor-Robinson, Apurba Majumder, Abdul Muktadir, Hasneen Muktadir, et al. (+4)
66 [GO] 2020―May―30 COVID-19 cytokine storm: The anger of inflammation Mehdi Mahmudpour, Jamshid Roozbeh, Mohsen Keshavarz, Shokrollah Farrokhi, Iraj Nabipour
67 [GO] 2020―May―21 Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions Rezvan Noroozi, Wojciech Branicki, Krzysztof Pyrc, Paweł P. Łabaj, Ewelina Pospiech, Mohammad Taheri, Soudeh Ghafouri-Fard
 [1] 

67 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.043 sec